Pulmonary tuberculosis (TB) is a major global health issue, especially in low‐and middle‐income countries. Early diagnosis is crucial to control TB and reduce morbidity and mortality. High‐Resolution Computed Tomography (HRCT) has emerged as a superior imaging tool compared to chest radiography, offering detailed visualization of lung abnormalities, such as cavitation, consolidation and the "tree‐in‐bud" pattern. This study evaluates the role of HRCT in the early diagnosis and management of pulmonary TB. A prospective observational study was conducted on 40 patients with suspected pulmonary TB at Sree Mookambika Institute of Medical Sciences between November 2023 and April 2024. HRCT scans were performed on all patients after suggestive or inconclusive chest radiographs. Patients with previous TB history were excluded. Key HRCT findings, including consolidation, cavitation, tree‐in‐bud appearance and fibrosis, were analyzed. Clinical data, sputum results and treatment decisions based on HRCT findings were recorded. Disease status (active or inactive TB) was classified based on HRCT. The majority of patients (37.5%) were between 31‐50 years of age, with males accounting for 67.5%. HRCT revealed the tree‐in‐bud appearance in 65% of cases, followed by consolidation (50%) and cavitation (45%). Active TB was diagnosed in 75% of cases based on HRCT findings, leading to the initiation of anti‐TB therapy. HRCT influenced treatment modifications in 30% of patients and guided surgical referrals in 7.5%. Clinical improvement was noted in 80% of patients following HRCT‐guided management. HRCT plays a crucial role in the early diagnosis and management of pulmonary TB. It is particularly useful in detecting subtle lung changes, differentiating between active and inactive TB and guiding treatment decisions. Its use can improve clinical outcomes, especially in resource‐limited settings where accurate diagnosis is essential for timely intervention.
R. Dayaakar, Sathish Babu and Rohit . Role of HRCT in Early Diagnosis and Management of Pulmonary Tuberculosis.
DOI: https://doi.org/10.36478/10.36478/makrjms.2024.12.356.360
URL: https://www.makhillpublications.co/view-article/1815-9346/10.36478/makrjms.2024.12.356.360